Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Hematological Cancer (Blood Cancer) Therapeutics- Market Insights, Competitive Landscape and, Market Forecast - 2027
... End-User (Hospital Pharmacies, Retail Pharmacy, And Others) and by geography is expected to grow at a steady CAGR forecast till 2027 owing to the increasing prevalence of blood cancer and increasing prevalence of lifestyle disorders ... Read More
-
KPL-716 Emerging Drug Insight and Market Forecast − 2032
... of the KPL-716 for Chronic Spontaneous Urticaria in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
NurOwn (MSC-NTF Cells) Emerging Drug Insight and Market Forecast – 2032
... the 7MM. A detailed picture of the NurOwn (MSC-NTF Cells) for Amyotrophic Lateral Sclerosis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period ... Read More
-
Gout Therapeutics Market (Drug Type: NSAIDS, Colchicine, Corticosteroids, Urate-lowering Drugs, and Biologics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... gout therapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report ... Read More
-
Pegcetacoplan (APL-2) Emerging Drug Insight and Market Forecast – 2032
... detailed picture of the Pegcetacoplan (APL-2) for Amyotrophic Lateral Sclerosis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in ... Read More
-
INCB050465 (Parsaclisib) Emerging Drug Insight and Market Forecast – 2032
... detailed picture of the INCB050465 (Parsaclisib) for Cold Agglutinin Disease in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in ... Read More
-
Europe Artificial Intelligence (AI) in Drug Discovery Market - Industry Trends and Forecast to 2029
... period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2022 to 2029. Market Segmentation Europe Artificial ... Read More
-
Progressive Pulmonary Fibrosis (PPF) - Market Insights, Epidemiology, and Market Forecast–2032
... and forecasted epidemiology as well as the Progressive pulmonary fibrosis (PPF) market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. The Progressive pulmonary fibrosis (PPF) market report ... Read More
-
Paclitaxel trevatide (ANG1005) Emerging Drug Insight and Market Forecast – 2032
... 7MM. A detailed picture of the Paclitaxel trevatide (ANG1005) for Leptomeningeal Metastases in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is ... Read More
-
Omburtamab Emerging Drug Insight and Market Forecast – 2032
... Omburtamab for Leptomeningeal Metastases in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
-
Biopreservation Market Share, Size, Trends, Industry Analysis Report, By Product (Equipment, Media, LIMS); By Application (Regenerative Medicine, Bio-banking, Drug Discovery); By Cell Providers Volume; By Region; Segment Forecast, 2022 - 2030
... size is expected to reach USD 15.12 billion by 2030, according to a new study by Polaris Market Research. The report “Biopreservation Market Share, Size, Trends, Industry Analysis Report, By Product (Equipment, Media, LIMS); By ... Read More
-
3D Cell Culture Market By Product (Scaffold Based Platforms, Scaffold Free Platforms, Gels, Bioreactors, Microchips, Services), By Application (Cancer Research, Stem Cell Research, Drug Discovery, Regenerative medicine), By End User (Biotechnology and Pharmaceutical Companies, Contract Research Laboratories, Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Research Laboratories, Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2021-2031 A 3D cell culture is an in-vitro technique wherein the cells can grow in an artificially created environment. These environments closely resemble the architecture ... Read More
-
Cytokine Release Syndrome - Market Insight, Epidemiology And Market Forecast - 2032
... forecasted epidemiology as well as the cytokine release syndrome market trends in the United States, the EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The cytokine release syndrome market report provides current treatment ... Read More
-
BIVV020 (SAR445088) Emerging Drug Insight and Market Forecast – 2032
... detailed picture of the BIVV020 (SAR445088) for Cold Agglutinin Disease in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in ... Read More
-
Ulcerated Necrobiosis Lipoidica -Market Insights, Epidemiology, and Market Forecast–2032
... as the Ulcerated Necrobiosis Lipoidica market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. The Ulcerated Necrobiosis Lipoidica market report provides current treatment practices, emerging drugs, market ... Read More
-
EMPAVELI/ASPAVELI Emerging Drug Insight and Market Forecast – 2032
... the EMPAVELI/ASPAVELI for Cold Agglutinin Disease in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with ... Read More
-
Alzheimer’s Therapeutics Market By Drug Class (Cholinesterase inhibitors, N-Methyl-D-Aspartate (NMDA) receptor antagonist, Others), By Distribution Channel (Hospital Pharmacy, Drug Store and Retail Pharmacy, Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2021-2031
... therapeutics market was valued $6,123 million in 2021 and expected to reach $13017.93 million by 2031, with a CAGR of 8.1% from 2022 to 2031. Alzheimer’s disease is a brain disorder, which slowly destroys memory ... Read More
-
VRAYLAR Emerging Drug Insight and Market Forecast – 2032
... of the VRAYLAR for Treatment Resistant Depression in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
LOU064 Emerging Drug Insight and Market Forecast − 2032
... of the LOU064 for Chronic Spontaneous Urticaria in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
Urticaria Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... than 80 million diagnosed prevalent cases of urticaria across 16 pharmaceutical markets. Most of the leading marketed drugs for urticaria are second-generation H1-antihistamines, which are used as the first-line symptomatic treatment for the disease. Out ... Read More
-
Methicillin-Resistant Staphylococcus Aureus (MRSA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... will be more than 859,000 incident cases of MRSA across seven major pharmaceutical markets. There are eight leading marketed drugs for the treatment of MRSA; Pfizer is a key player in the disease space. R&D ... Read More
-
Fungal Infections Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... be more than three million incident cases of fungal Infections across 16 pharmaceutical markets. There are several marketed innovator drugs for the treatment of fungal infections, mostly cytochrome P450 and beta glucan synthase enzyme inhibitors. ... Read More
-
Rabies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Rabies (Infectious Disease) pipeline landscape. Rabies is a deadly virus spread to people from the saliva of infected animals. The rabies virus is usually transmitted through a bite. Symptoms include loss of ... Read More
-
Essential Thrombocythemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Essential Thrombocythemia (Oncology) pipeline landscape. Essential thrombocythemia is a chronic myeloproliferative neoplasm in which cells in the bone marrow that produce the blood cells develop and function abnormally. In essential ... Read More
-
Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Osteoporosis (Metabolic Disorders) pipeline landscape. Osteoporosis, or thinning bones, makes bones weak and more likely to break. Risk factors for osteoporosis include aging, being female, low body weight, low sex hormones or ... Read More
Research Assistance
